Full history for every metric is available with a Kvantra account
Stock profile
Chemon Inc (217600.KS)
Current price
2,170.00 KRW0.00%
Last close 15 Dec 2022Benchmarks
Key financial summary
Financials in KRW| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | KRW bn | 0 | 16 | 19 | 21 | 25 | 29 | 43 |
| Operating profit | KRW bn | 4 | 9 | |||||
| Net profit | KRW bn | 0 | -2 | 1 | 2 | 2 | 4 | 8 |
| EPS reported | KRW | 68.44 | 128.2 | |||||
| Operating cashflow per share | KRW | 104.6 | 104.6 | |||||
| Capex per share | KRW | 251.6 | 251.6 | |||||
| FCF per share | KRW | -147.1 | -147.1 | |||||
| Free cash flow | KRW bn | -9 | -7 | |||||
| Net debt | KRW bn | -20 | -14 | |||||
| Book value equity | KRW bn | 59 | 66 | |||||
| Book value per share | KRW | 923.1 | 1,028 | |||||
| Number of shares | m | 63.86 | 63.86 | |||||
| DPS (TTM paid) | KRW | 0.00 | 0.00 |
Financial summary
Financials in KRW| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | 54.06 | - | |||||
| P/B LTM | x | 4.01 | 2.35 | |||||
| P/S LTM | x | 8.11 | 0.00 | |||||
| P/FCF LTM | x | -25.16 | 0.00 | |||||
| EV/EBITDA LTM | x | 31.94 | 0.34 | |||||
| EV/Sales LTM | x | 8.20 | 0.09 | |||||
| Earnings Yield LTM | % | 1.85% | 3.15% | |||||
| FCF Yield | % | -3.97% | - | |||||
| Quality | ||||||||
| ROE | % | 7.41% | 7.69% | |||||
| ROIC | % | 5.56% | 5.56% | |||||
| Operating margin | % | 13.99% | 13.99% | |||||
| Gross margin | % | 26.54% | 26.54% | |||||
| FCF/Sales | % | -32.23% | -32.23% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | +113.88% | +129.09% | |||||
| Sales Growth YoY | % | +17.66% | +48.57% | |||||
| Net Income Growth YoY | % | +127.53% | +137.38% | |||||
| FCF Growth | % | - | - | |||||
| Operating Profit Growth | % | +67.47% | +101.26% | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | -1.20 | -0.80 | |||||
| Net Debt/EBITDA | x | 0.34 | 0.34 | |||||
| EBIT/Net interest | x | 49.41 | 49.41 | |||||
| Net debt/market cap | % | -8.50% | - | |||||
| Net debt/Equity | x | -0.34 | -0.22 | |||||
| Gross debt/equity | x | 0.13 | 0.14 | |||||
Company overview
No description available.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
21
Chemon Inc (217600.KS)
217600.KS · KSC · Healthcare
2,170.00 KRW0.00%
Benchmarks
Financialsin KRW
20202021TTM
Total revenue KRW bn252943
Operating profit KRW bn49
Net profit KRW bn248
EPS reported KRW68.44128.2
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free